New HIV drug can only offer hope of ending AIDS if all have …
WEBGENEVA, 10 July 2024— UNAIDS has welcomed the release of Gilead Sciences’ trial results on the injectable long-acting HIV medicine Lenacapavir for HIV prevention. The result “provides hope of accelerating efforts to end AIDS”, UNAIDS says, “but only if Gilead ensures that all people who need it can have access to this game-changing ...
Clinical trial begins using CAR T cells to potentially cure HIV
WEBApr 19, 2023 · UC Davis Health researchers have dosed the second participant in their clinical trial looking to identify a potential cure for HIV utilizing CAR T-cell therapy. The novel study uses immunotherapy.
Researchers a step closer to a cure for HIV | ScienceDaily
WEBMar 26, 2024 · A new study shows virus-like particle can effectively 'shock and kill' latent HIV reservoir in those living with chronic HIV.
Proof-of-concept study to find functional cure for HIV
WEBJul 24, 2024 · Researchers in George Mason University's Center for Infectious Disease Research (CIDR) and Tulane National Primate Research Center conducted a breakthrough proof-of-concept study in Nature 's Gene...
New Trial Highlights Incremental Progress Towards a Cure for HIV-1
WEBFeb 13, 2024 · If ART is discontinued, HIV will awaken from its dormant state, begin to replicate, and cause acquired immunodeficiency syndrome (AIDS). To create a cure, researchers have been attempting to drive HIV out of latency and target it for destruction.
George Mason researchers lead breakthrough study to find …
WEBJul 25, 2024 · Researchers in George Mason University’s Center for Infectious Disease Research (CIDR) and Tulane National Primate Research Center conducted a breakthrough proof-of-concept study, published in Nature’s Gene Therapy, that found a human immunodeficiency virus (HIV)-like virus particle that could cease the need for …
Beginning of end of HIV epidemic? — Harvard Gazette
WEBJul 24, 2024 · Researchers may have found a powerful new preventative against the AIDS virus, which has killed more than 40 million people since the epidemic began in 1981. In late June, a trial of lenacapavir, an existing anti-HIV drug used to reduce infection, produced an astonishing result: None of the more than 2,100 young female participants in the test ...
New trial highlights incremental progress towards a cure for HIV-1
WEBFeb 13, 2024 · A new clinical trial suggests that a combination of the drug vorinostat and immunotherapy can coax HIV-infected cells out of latency and attack them. The findings highlight how close -- yet...
Seventh patient ‘cured’ of HIV: why scientists are excited - Nature
WEBJul 26, 2024 · To many scientists, these cases suggested that CCR5 was the best target for an HIV cure. The latest case — presented at the 25th International AIDS Conference in Munich, Germany, this week —...
First two patients receive CAR T cell therapy for HIV - Nature
WEBMay 9, 2023 · Two patients have received infusions of an investigational chimeric antigen receptor (CAR) T cell that targets the human immunodeficiency virus (HIV) envelope glycoprotein gp120 (LVgp120duoCAR-T...